Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation. (12th June 2016)
- Record Type:
- Journal Article
- Title:
- Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation. (12th June 2016)
- Main Title:
- Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation
- Authors:
- Kumagai, Arisa
Kondo, Fukuo
Sano, Keiji
Inoue, Masafumi
Fujii, Takeshi
Hashimoto, Masaji
Watanabe, Masato
Soejima, Yurie
Ishida, Tsuyoshi
Tokairin, Takuo
Saito, Koji
Sasajima, Yuko
Takahashi, Yoshihisa
Uozaki, Hiroshi
Fukusato, Toshio - Abstract:
- Abstract: Background: The purpose of this study is to investigate whether ordinary hepatocellular carcinomas (HCCs) show positivity of stem/progenitor cell markers and cholangiocyte markers during the process of tumor progression. Methods: Ninety‐four HCC lesions no larger than 8 cm from 94 patients were immuno‐histochemically studied using two hepatocyte markers (Hep par 1 and α‐fetoprotein), five cholangiocyte markers (cytokeratin CK7, CK19, Muc1, epithelial membrane antigen and carcinoembryonic antigen) and three hepatic stem/progenitor cell markers (CD56, c‐Kit and EpCAM). The tumors were classified into three groups by tumor size: S1, < 2.0 cm; S2, 2.0–5.0 cm; S3, 5.0–8.0 cm. The tumors were also classified according to tumor differentiation: well, moderately and poorly differentiated. The relationship between the positive ratios of these markers, tumor size and tumor differentiation was examined. Results: The positive ratios of cholangiocyte markers tended to be higher in larger sized and more poorly differentiated tumors (except for CK7). The positive ratios of stem/progenitor cell markers tended to be higher in larger sized and more poorly differentiated tumors (except for c‐Kit). Conclusion: Ordinary HCC can acquire the characteristic of positivity of cholangiocyte and stem/progenitor cell markers during the process of tumor progression. Abstract : Highlight Kumagai and colleagues showed that the positive ratios of cholangiocyte and stem/progenitor cell markersAbstract: Background: The purpose of this study is to investigate whether ordinary hepatocellular carcinomas (HCCs) show positivity of stem/progenitor cell markers and cholangiocyte markers during the process of tumor progression. Methods: Ninety‐four HCC lesions no larger than 8 cm from 94 patients were immuno‐histochemically studied using two hepatocyte markers (Hep par 1 and α‐fetoprotein), five cholangiocyte markers (cytokeratin CK7, CK19, Muc1, epithelial membrane antigen and carcinoembryonic antigen) and three hepatic stem/progenitor cell markers (CD56, c‐Kit and EpCAM). The tumors were classified into three groups by tumor size: S1, < 2.0 cm; S2, 2.0–5.0 cm; S3, 5.0–8.0 cm. The tumors were also classified according to tumor differentiation: well, moderately and poorly differentiated. The relationship between the positive ratios of these markers, tumor size and tumor differentiation was examined. Results: The positive ratios of cholangiocyte markers tended to be higher in larger sized and more poorly differentiated tumors (except for CK7). The positive ratios of stem/progenitor cell markers tended to be higher in larger sized and more poorly differentiated tumors (except for c‐Kit). Conclusion: Ordinary HCC can acquire the characteristic of positivity of cholangiocyte and stem/progenitor cell markers during the process of tumor progression. Abstract : Highlight Kumagai and colleagues showed that the positive ratios of cholangiocyte and stem/progenitor cell markers tended to be higher in larger sized and less differentiated hepatocellular carcinoma, indicating that ordinary hepatocellular carcinoma can acquire the characteristics of positivity of cholangiocyte and stem/progenitor cell markers during the process of tumor progression. … (more)
- Is Part Of:
- Journal of hepato-biliary-pancreatic sciences. Volume 23:Number 7(2016)
- Journal:
- Journal of hepato-biliary-pancreatic sciences
- Issue:
- Volume 23:Number 7(2016)
- Issue Display:
- Volume 23, Issue 7 (2016)
- Year:
- 2016
- Volume:
- 23
- Issue:
- 7
- Issue Sort Value:
- 2016-0023-0007-0000
- Page Start:
- 414
- Page End:
- 421
- Publication Date:
- 2016-06-12
- Subjects:
- Hepatocellular carcinoma -- Immunohistochemistry -- Progenitor cell -- Stem cell -- Transdifferentiation
Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
617.556 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1868-6982 ↗
http://www.springerlink.com/content/121581 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jhbp.356 ↗
- Languages:
- English
- ISSNs:
- 1868-6974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4997.660000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2252.xml